Dotinurad restores exacerbated kidney dysfunction in hyperuricemic patients with chronic kidney disease
Abstract Background In this study, we aimed to clarify the beneficial effects of urate-lowering treatment with the novel agent dotinurad on renal function in patients with chronic kidney disease (CKD) and hyperuricemia (HUA). Methods Thirty-five patients with CKD (mean age 65.4 ± 14.8 years, 23 men)...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-03-01
|
| Series: | BMC Nephrology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12882-024-03535-9 |